Live Roundups Editor's Desk Insights Executive Ops Weather About 🔍
Home › Health › Moderna’s stock doubles on promising cancer-vaccine results
Health

Moderna’s stock doubles on promising cancer-vaccine results

Moderna’s stock doubles on promising cancer-vaccine results
MarketWatch Wednesday 19 August 2026, 12:15 UTC By Jaimy Lee 1 min read
Key Points

The vaccine candidate pairs an mRNA therapy with the cancer drug Keytruda.

The vaccine candidate pairs an mRNA therapy with the cancer drug Keytruda.
Moderna (ORG) Keytruda (ORG)
Originally published by MarketWatch Read original →

Related Stories

Experimental mRNA drug makes breakthrough in deadly skin cancer treatment

Experimental mRNA drug makes breakthrough in deadly skin cancer treatment More than 8,500 Americans are expected to die of melanoma this year - Bookmark - CommentsGo to comments An experimental mRNA cancer drug has been found to stop the spread and return of melanoma for the first time, a potentially game-changing breakthrough for people with life-threatening skin cancer. The therapy called intismeran, which personalized for each patient, succeeded in preventing melanoma from coming back or...

The Independent World 14m ago

TV doctor calls on government to take action on life expectancy gap across UK

TV doctor calls on government to take action on life expectancy gap across UK TV Doctor Amir Khan has called on the Government to end 'postcode inequality' in healthcare. Dr Amir Khan, a media medic and author, has described life expectancy disparities as a 'national crisis' after it emerged those living in affluent places like Marylebone and Berkhamsted are living up to 18 years longer than those in generally poorer areas like Blackpool and Glasgow. The life expectancy figures in the...

Daily Mirror 25m ago

Former Fauci adviser pleads guilty to conspiracy to conceal Covid-19 records

David Morens confessed to concealing government documents linked to grant research fundingA former adviser to infectious disease expert Anthony Fauci pleaded guilty on Tuesday to conspiring to evade public records laws and conceal government documents related to ​grant research funding and the Covid-19 pandemic. David Morens, who had worked under Fauci ‌as a senior official at the National Institute of Allergy and Infectious Diseases during the pandemic, entered his plea, to a conspiracy...

The Guardian World 31m ago

Former Fauci adviser pleads guilty to conspiracy to conceal Covid-19 records

David Morens confessed to concealing government documents linked to grant research fundingA former adviser to infectious disease expert Anthony Fauci pleaded guilty on Tuesday to conspiring to evade public records laws and conceal government documents related to ​grant research funding and the Covid-19 pandemic. David Morens, who had worked under Fauci ‌as a senior official at the National Institute of Allergy and Infectious Diseases during the pandemic, entered his plea, to a conspiracy...

The Guardian UK 31m ago